{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:24:26Z","timestamp":1764174266085},"reference-count":20,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2016,9,12]],"date-time":"2016-09-12T00:00:00Z","timestamp":1473638400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Nephrology"],"published-print":{"date-parts":[[2016,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In this prospective observational cohort study, we evaluate the change in cardiovascular risk parameters, with a focus on lipids, in live kidney donors 1\u2009year post donation. Body mass index, systolic\/diastolic blood pressure, kidney function (chromium\u201051 ethylenediaminetetraacetic acid estimated glomerular filtration) and lipid parameters were measured at baseline and 1\u2009year. Data on 87 live kidney donors were collected. Body mass index increased from 26.5\u2009\u00b1\u20092.7 pre to 27.4\u2009\u00b1\u20093.0\u2009kg\/m<jats:sup>2<\/jats:sup> post donation (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001). Chromium\u201051 ethylenediaminetetraacetic acid estimated glomerular filtration decreased from 111.8\u2009\u00b1\u200920.0 pre to 72.1\u2009\u00b1\u200913.1\u2009mL\/min\/1.73\u2009m<jats:sup>2<\/jats:sup> post donation (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001). Serum triglyceride levels increased from 0.8 (interquartile range 0.6\u20131.3) pre to 1.0\u2009mmol\/L (interquartile range 0.7\u20131.6) post donation (<jats:italic>p<\/jats:italic>\u2009=\u20090.0004). Statin use increased from 11.5% pre to 21% post donation (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.005). Low\u2010density lipoprotein remained stable, and other lipids (high\u2010density lipoprotein, apolipoprotein B and lipoprotein a) did not change post donation.<\/jats:p>","DOI":"10.1111\/nep.12792","type":"journal-article","created":{"date-parts":[[2016,4,10]],"date-time":"2016-04-10T16:04:36Z","timestamp":1460304276000},"page":"901-904","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Live donor study \u2013 implications of kidney donation on cardiovascular risk with a focus on lipid parameters including lipoprotein a"],"prefix":"10.1111","volume":"21","author":[{"given":"Brian","family":"Doucet","sequence":"first","affiliation":[{"name":"Department of Cardiology Mater Misericordiae Hospital  Brisbane Queensland Australia"},{"name":"School of Medicine University of Queensland  Brisbane Queensland Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karam","family":"Kostner","sequence":"additional","affiliation":[{"name":"Department of Cardiology Mater Misericordiae Hospital  Brisbane Queensland Australia"},{"name":"School of Medicine University of Queensland  Brisbane Queensland Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Kaiser","sequence":"additional","affiliation":[{"name":"Department of Nephrology Princess Alexandra Hospital  Brisbane Queensland Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmel","family":"Hawley","sequence":"additional","affiliation":[{"name":"School of Medicine University of Queensland  Brisbane Queensland Australia"},{"name":"Department of Nephrology Princess Alexandra Hospital  Brisbane Queensland Australia"},{"name":"Translational Research Institute  Brisbane Queensland Australia"},{"name":"Australasian Kidney Trials Network University of Queensland  Brisbane Queensland Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Isbel","sequence":"additional","affiliation":[{"name":"School of Medicine University of Queensland  Brisbane Queensland Australia"},{"name":"Department of Nephrology Princess Alexandra Hospital  Brisbane Queensland Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,9,12]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.285141"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2013.460"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000436906.48802.c4"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-145-3-200608010-00006"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001819"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041031"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006091006"},{"key":"e_1_2_6_9_1","volume-title":"Kidney Protocol \u2013 The Allocation of Transplant Kidneys in Australia","author":"The Transplantation Society of Australia and New Zealand (TSANZ)","year":"2011"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3181b27a17"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01350209"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfp640"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt.gft302"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(15)00128-X"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2000.00384.x"},{"key":"e_1_2_6_16_1","first-page":"213","article-title":"Plasma triglycerides is a risk factor for cardiovascular disease independent of high density lipoprotein cholesterol: a meta analyses of population based prospective studies","volume":"3","author":"Hokanson JE","year":"1996","journal-title":"J Cardiovasc Res."},{"key":"e_1_2_6_17_1","first-page":"28B","article-title":"Advances in drug treatment of dyslipidaemia: focus on atorvastatin","volume":"14","author":"Davignon J","year":"1998","journal-title":"Can. J. Cardiol."},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(90)90046-F"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-013-0875-8"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9150(81)90103-9"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.2217\/bmm.11.60"}],"container-title":["Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fnep.12792","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/nep.12792","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T00:35:23Z","timestamp":1696206923000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/nep.12792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,12]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["10.1111\/nep.12792"],"URL":"https:\/\/doi.org\/10.1111\/nep.12792","archive":["Portico"],"relation":{},"ISSN":["1320-5358","1440-1797"],"issn-type":[{"value":"1320-5358","type":"print"},{"value":"1440-1797","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,12]]},"assertion":[{"value":"2015-10-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-04-01","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-09-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}